Eliza Lee is a Lead Scientist at Samsung Biologics, a leading CDMO. With over 14 years of extensive experience in the fields of R&D and biopharma, Ms Lee plays a significant role in leading the company’s analytical programme management, from method development to release and stability, as well as extended characterisation. Ms Lee acquired her Bachelor of Bioengineering degree from the University of California, Berkeley (US).